A randomized, 12 months, active controlled study of the efficacy of repeated doses of intravitreal aflibercept in subjects with prolipherative diabetic retinopathy.
Phase of Trial: Phase II
Latest Information Update: 24 Nov 2016
At a glance
- Drugs Aflibercept (Primary)
- Indications Diabetic retinopathy
- Focus Therapeutic Use
- 24 Nov 2016 New trial record